Active13680871Private limited companyCambridge

GRAEGIS PHARMACEUTICALS LIMITED

Significant control: Aldena Therapeutics (UK) Ltd (75–100%)

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Graegis Pharmaceuticals Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Graegis Pharmaceuticals Limited sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

GRAEGIS PHARMACEUTICALS LIMITED is an active private limited company (company number 13680871) incorporated on 14 October 2021, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (small) but not yet parsed into this record.

There are 196 companies in research and experimental development on biotechnology in Cambridge with filed accounts; the median reports net assets of £15k and is 7 years old.

Ownership and control

1 active · 5 other

Aldena Therapeutics (Uk) Ltd
corporate entity, England · since 2 June 2026
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
75–100%
RM
Mr Richard Michael Lee
Individual · since 14 October 2021 · ceased 1 December 2021
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
75–100%
Medicxi Iii Lp
corporate entity, Jersey · since 1 December 2021 · ceased 14 October 2023
- owns 25–50% of shares
25–50%
Clevexel Pharma
corporate entity, France · since 20 December 2021 · ceased 1 August 2023
- owns 25–50% of shares
25–50%
Clevexel Pharma
corporate entity, France · since 1 August 2023 · ceased 14 October 2023
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%
persons with significant control statement · since 14 October 2023 · ceased 2 June 2026

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 14 October 20215 yrs ago
First accounts due: 14 July 20231203 days overdue
Confirmation statement due: 28 October 20261 days overdue

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
Accounts type: Small

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

Filing and accounts signals

Facts from the register · no rating

Incorporated two to five years agoIncorporated 14 October 2021
Accounts past their due dateDue 14 July 2023

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

28 Oct 2026Confirmation statement due1 days overdue
14 Jul 2023First accounts due1203 days overdue
14 Oct 2021Incorporated

Similar companies in Cambridge

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 14 October 2021 · in Oct 2021.

Reminders for GRAEGIS PHARMACEUTICALS LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.